DiMasi, J. A., Grabowski, H. G. & Hansen, R. W. Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 47, 20–33 (2016).ArticleÂ
Google ScholarÂ
Swinney, D. C. & Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov. 10, 507–519 (2011).ArticleÂ
Google ScholarÂ
Rask-Andersen, M., Almen, M. S. & Schioth, H. B. Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov. 10, 579–590 (2011).ArticleÂ
Google ScholarÂ
Lee, H. & Lee, J. W. Target identification for biologically active small molecules using chemical biology approaches. Arch. Pharm. Res. 39, 1193–1201 (2016).ArticleÂ
Google ScholarÂ
Ha, J. et al. Recent advances in identifying protein targets in drug discovery. Cell Chem. Biol. 28, 394–423 (2021).ArticleÂ
Google ScholarÂ
Boutros, M., Heigwer, F. & Laufer, C. Microscopy-based high-content screening. Cell 163, 1314–1325 (2015).ArticleÂ
Google ScholarÂ
Chandrasekaran, S. N. et al. Image-based profiling for drug discovery: due for a machine-learning upgrade? Nat. Rev. Drug Discov. 20, 145–159 (2021).ArticleÂ
Google ScholarÂ
Caicedo, J. C. et al. Data-analysis strategies for image-based cell profiling. Nat. Methods 14, 849–863 (2017).ArticleÂ
Google ScholarÂ
Way, G. P. et al. Morphology and gene expression profiling provide complementary information for mapping cell state. Cell Syst. 13, 911–923 e9 (2022).ArticleÂ
Google ScholarÂ
Funk, L. et al. The phenotypic landscape of essential human genes. Cell 185, 4634–4653 e22 (2022).ArticleÂ
Google ScholarÂ
Thyme, S. B. et al. Phenotypic landscape of schizophrenia-associated genes defines candidates and their shared functions. Cell 177, 478–491.e20 (2019).ArticleÂ
Google ScholarÂ
Simm, J. et al. Repurposing high-throughput image assays enables biological activity prediction for drug discovery. Cell Chem. Biol. 25, 611–618.e3 (2018).ArticleÂ
Google ScholarÂ
Nyffeler, J. et al. Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling. Toxicol. Appl. Pharmacol. 389, 114876 (2020).ArticleÂ
Google ScholarÂ
Pegoraro, G. & Misteli, T. High-throughput imaging for the discovery of cellular mechanisms of disease. Trends Genet. 33, 604–615 (2017).ArticleÂ
Google ScholarÂ
Bray, M. A. et al. Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat. Protoc. 11, 1757–1774 (2016).ArticleÂ
Google ScholarÂ
Hofmarcher, M. et al. Accurate prediction of biological assays with high-throughput microscopy images and convolutional networks. J. Chem. Inf. Model. 59, 1163–1171 (2019).ArticleÂ
Google ScholarÂ
Perlman, Z. E. et al. Multidimensional drug profiling by automated microscopy. Science 306, 1194–1198 (2004).Lin, J. R., Fallahi-Sichani, M. & Sorger, P. K. Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method. Nat. Commun. 6, 8390 (2015).ArticleÂ
Google ScholarÂ
Nunnari, J. & Suomalainen, A. Mitochondria: in sickness and in health. Cell 148, 1145–1159 (2012).ArticleÂ
Google ScholarÂ
Russell, O. M. et al. Mitochondrial diseases: hope for the future. Cell 181, 168–188 (2020).ArticleÂ
Google ScholarÂ
Jangili, P. et al. DNA-damage-response-targeting mitochondria-activated multifunctional prodrug strategy for self-defensive tumor therapy. Angew. Chem. Int. Ed. 61, e202117075 (2022).ArticleÂ
Google ScholarÂ
Carelli, V. & Chan, D. C. Mitochondrial DNA: impacting central and peripheral nervous systems. Neuron 84, 1126–1142 (2014).ArticleÂ
Google ScholarÂ
Glancy, B. Visualizing mitochondrial form and function within the cell. Trends Mol. Med. 26, 58–70 (2020).ArticleÂ
Google ScholarÂ
Cretin, E. et al. High-throughput screening identifies suppressors of mitochondrial fragmentation in OPA1 fibroblasts. EMBO Mol. Med. 13, e13579 (2021).ArticleÂ
Google ScholarÂ
Varkuti, B. H. et al. Neuron-based high-content assay and screen for CNS active mitotherapeutics. Sci. Adv. 6, eaaw8702 (2020).ArticleÂ
Google ScholarÂ
Chandrasekharan, A. et al. A high-throughput real-time in vitro assay using mitochondrial targeted roGFP for screening of drugs targeting mitochondria. Redox Biol. 20, 379–389 (2019).ArticleÂ
Google ScholarÂ
Iannetti, E. F. et al. Multiplexed high-content analysis of mitochondrial morphofunction using live-cell microscopy. Nat. Protoc. 11, 1693–1710 (2016).ArticleÂ
Google ScholarÂ
Pereira, G. C. et al. Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol. Curr. Pharm. Des. 17, 2113–2129 (2011).ArticleÂ
Google ScholarÂ
Varga, Z. V. et al. Drug-induced mitochondrial dysfunction and cardiotoxicity. Am. J. Physiol. Heart. Circ. Physiol. 309, H1453–H1467 (2015).ArticleÂ
Google ScholarÂ
Stringer, C. et al. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100–106 (2021).ArticleÂ
Google ScholarÂ
Cao, M. et al. Plant exosome nanovesicles (PENs): green delivery platforms. Mater. Horiz. 10, 3879–3894 (2023).ArticleÂ
Google ScholarÂ
Zhang, D. et al. Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy. Nat. Commun. 13, 1413 (2022).ArticleÂ
Google ScholarÂ
Ji, X. et al. Capturing functional two-dimensional nanosheets from sandwich-structure vermiculite for cancer theranostics. Nat. Commun. 12, 1124 (2021).ArticleÂ
Google ScholarÂ
Zhong, D. et al. Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Sci. Adv. 7, eabi9265 (2021).ArticleÂ
Google ScholarÂ
Chen, F. et al. The V-ATPases in cancer and cell death. Cancer Gene Ther. 29, 1529–1541 (2022).ArticleÂ
Google ScholarÂ
Rizzuto, R. et al. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 13, 566–578 (2012).ArticleÂ
Google ScholarÂ
Giorgi, C., Marchi, S. & Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 19, 713–730 (2018).ArticleÂ
Google ScholarÂ
Schmitt, N., Grunnet, M. & Olesen, S. P. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia. Physiol. Rev. 94, 609–653 (2014).ArticleÂ
Google ScholarÂ
Lei, M. et al. Modernized classification of cardiac antiarrhythmic drugs. Circulation 138, 1879–1896 (2018).ArticleÂ
Google ScholarÂ
Zheng, Z., Zheng, L. & Yang, Y. A discriminatively learned CNN embedding for person reidentification. In ACM Transactions on Multimedia Computing, Communications, and Applications (TOMM) Vol. 14, 1–20 (ACM, 2017).Luo, H. et al. Bag of tricks and a strong baseline for deep person re-identification. In Proc. IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (IEEE, 2019).Carreira, J. & A. Zisserman. Quo vadis, action recognition? A new model and the kinetics dataset. Proc. IEEE Conference on Computer Vision and Pattern Recognition 6299–6308 (IEEE, 2017).Hermans, A., Beyer, L. & Leibe, B. In defense of the triplet loss for person re-identification. Preprint at https://arxiv.org/abs/1703.07737 (2017).Wen, Y. et al. A discriminative feature learning approach for deep face recognition. In European Conference On Computer Vision 499–515 (Springer, 2016).Szegedy, C. et al. Rethinking the inception architecture for computer vision. Proc. IEEE Conference On Computer Vision And Pattern Recognition 2818–2826 (2016).Moon, H. & Phillips, P. J. Computational and performance aspects of PCA-based face-recognition algorithms. Perception 30, 303–321 (2001).ArticleÂ
Google ScholarÂ
Zheng, L. et al. Scalable person re-identification: a benchmark. In Proc. IEEE International Conference On Computer Vision 1116–1124 (IEEE, 2015).Atanasov, A. G. et al. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200–216 (2021).ArticleÂ
Google ScholarÂ
Zhou, J. et al. Graph neural networks: a review of methods and applications. AI Open 1, 57–81 (2020).ArticleÂ
Google ScholarÂ
Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16, 19–34 (2017).ArticleÂ
Google ScholarÂ
Corsello, S. M. et al. The drug repurposing hub: a next-generation drug library and information resource. Nat. Med. 23, 405–408 (2017).ArticleÂ
Google ScholarÂ
Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180–D1192 (2024).ArticleÂ
Google ScholarÂ
Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018).ArticleÂ
Google ScholarÂ
MetaXpress v.6.6 https://www.moleculardevices.com/products/cellular-imaging-systems/high-content-analysis/metaxpress (Molecular Devices, 2020).AutoDock v.4.2.6 https://autodock.scripps.edu/ (CCSB, 2014).ChemOffice v.19.0 https://revvitysignals.com/products/research/chemdraw (Revvity Signals, 2019).Goodsell, D. S. et al. RCSB Protein Data Bank: enabling biomedical research and drug discovery. Protein Sci. 29, 52–65 (2020).ArticleÂ
Google ScholarÂ
PyMOL v.2.5 https://pymol.org/ (Schrödinger, 2021).Zhang, S. et al. Discovery of herbacetin as a novel SGK1 inhibitor to alleviate myocardial hypertrophy. Adv. Sci. 9, e2101485 (2022).ArticleÂ
Google ScholarÂ
He, K. et al. Deep residual learning for image recognition. Proc. IEEE Conference On Computer Vision And Pattern Recognition 770–778 (IEEE, 2016).Schroff, F., Kalenichenko, D. & Philbin, P. FaceNet: a unified embedding for face recognition and clustering. In 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) (IEEE, 2015).He, K. et al. Delving deep into rectifiers: surpassing human-level performance on imagenet classification. Proc. IEEE International Conference On Computer Vision 1026–1034 (IEEE, 2015).LeCun, Y. et al. Backpropagation applied to handwritten ZIP Code recognition. Neural Comput. 1, 541–551 (1989).ArticleÂ
Google ScholarÂ
Li, W., Yu, M. & Wang, Y. Data for Deep Learning Large-Scale Drug Discovery and Repurposing (Zenodo, 2024); https://doi.org/10.5281/zenodo.12730131Li, W. liweim/MitoReID: v1.0 (Zenodo, 2024); https://doi.org/10.5281/zenodo.12726571